Carregant...
Evaluation of confirmatory data following the Article 12 MRL review for cyazofamid
The applicant ISK Biosciences Europe N.V. submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. The data gap which was related to in...
Guardat en:
| Publicat a: | EFSA J |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7009532/ https://ncbi.nlm.nih.gov/pubmed/32625765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2018.5487 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|